(Technology Bundle) Stem cells with transiently reduced p53 to treat diabetes associated kidney disease and peripheral vascular disease
Local delivery of endothelial progenitor cells (EPCs) may treat diabetic-related kidney disease (DKD) and peripheral vascular disease (PVD). EPCs may be obtained from a patient’s peripheral blood. The hyperglycemic state in diabetic patients causes transplanted EPCs to undergo apoptosis, creating a challenge for such therapies. By transiently...
Published: 1/7/2022
|
Updated: 11/16/2021
|
Inventor(s): Sabyasachi Sen
Keywords(s):
Category(s): Technology Classifications > Therapeutics > Cells
|